People with diabetes at significantly higher risk of developing carpal tunnel syndrome, finds study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2024-05-04 04:00 GMT | Update On 2024-05-04 06:17 GMT

People with diabetes are at significantly higher risk of developing carpal tunnel syndrome, according to a study published in PlosOne.

In recent years, several studies have reported on the relationship between diabetes and carpal tunnel syndrome (CTS). However, due to their contradictory results, a systematic review and meta-analysis were conducted to investigate this subject. This study is a systematic review and meta-analysis of studies published in ISI Web of Science, Scopus, PubMed, Cochrane, Google Scholar, and Embase databases. Heterogeneity in the studies included in the meta-analysis was evaluated using statistical tests such as the Chi-square test, I2, and forest plots. Publication bias was assessed using Begg’s and Egger’s tests.

Results: This investigation analyzed data from 42 studies conducted between 1985 and 2022, with a total of 3,377,816 participants. The meta-analysis demonstrated that the odds ratio (OR) of CTS in participants with a history of diabetes compared to those without was 1.90 (95% CI: 1.64–2.21; P-value < 0.001). Given that publication bias was observed in this study (Begg’s test P-value = 0.01), the modified OR was calculated with consideration of missed studies, which was 1.68 (95% CI: 1.45–1.94; P-value < 0.001). The results of this study suggest that diabetic patients have 90% higher odds of developing CTS compared to non-diabetic individuals, which is statistically significant.

Reference:

Sanjari E, Raeisi Shahraki H, G Khachatryan L, Mohammadian-Hafshejani A. Investigating the association between diabetes and carpal tunnel syndrome: A systematic review and meta-analysis approach. PLoS One. 2024 Apr 16;19(4):e0299442. doi: 10.1371/journal.pone.0299442. PMID: 38626071; PMCID: PMC11020394.

Article Source : Plos One

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

People with diabetes at significantly higher risk of developing carpal tunnel syndrome, finds study

Similar News

GLP-1 Receptor Agonists Reduce Cardiovascular and Kidney Risks in Lupus Patients with Type 2 Diabetes: Study

Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study

Sibutramine-Topiramate Combo Effective for Long-Term Weight Loss in Obesity: Study Finds

GLP-1 Drugs Cut Heart Risks in Overweight Diabetics, Safeguard Kidneys for All: JAMA

GLP-1RAs Show Promise for Kidney Protection in Type 2 Diabetes, Reveals Research

GLP-1 Receptor Agonists Show Gastrointestinal Safety with Some Risks: Study

Pneumococcal Vaccination in Hematological Malignancies (HM)-Indian Hematology Expert Consensus 2025

Bariatric Surgery Effective than Medical Management in Achieving Diabetes Remission: Study